| Heading: |
Respiratory Syncytial Virus: Disease Control |
| Question ID: |
1795941 |
| UIN: |
HL6737 |
| House: |
Lords |
| Date tabled: |
2025-04-22 |
| Asking Member ID: |
4130 |
| Asking Member display name: |
Baroness Ritchie of Downpatrick
|
| Asking Member handle: |
MRitchieSD
|
| Asking Member Twitter reference: |
@MRitchieSD
|
| Member interest: |
false |
| Question text: |
To ask His Majesty's Government what steps they are taking to ensure that patients at higher-risk of severe infection from infant respiratory syncytial virus, such as those with a pre-existing condition or born pre-term, are protected before winter. |
| Is named day: |
false |
| Date of holding answer: |
|
| Date answered: |
2025-04-30 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
347 |
| Answering Member display name: |
Baroness Merron
|
| Answering Member handle: |
|
| Answering Member Twitter reference: |
Baroness Merron
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
In line with independent expert advice from the Joint Committee on Vaccination and Immunisation (JCVI), respiratory syncytial virus (RSV) vaccination programmes were introduced in England in September 2024 to protect infants, via maternal vaccination, and... |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
17 |
| Answering body name: |
Department of Health and Social Care |
| Tweeted: |
true |